Member Info for chester18

Hi Nomlungu

Under those circumstances I can't see SAHPRA taking 5 or 6 weeks to process our application. It would be a fantastic outcome all round if a positive Safety Trial is dealt with quickly, ensuring that the Phase 2 part can start as soon as possible.

Lets hope that Covidity is the real deal.

Chester.

I've just read through the Scancell RNS and the Trinity Delta report but cannot find the 7/10 days comment. Other than the fact that C7 or KonarA re-posted it does anyone know where that information originated ??

Chester.

Ok got it, thanks KonarA

I don't use the thread view very often and for some reason I hadn't seen your post which is unusual.

I knew I'd read the 7/10 days comment. So maybe a decision end of next week is a possibility.

Chester.

Hi Bamps and Bottle,

Just got back from your fantastically informative tour of the Decline and Ore Face and realised I've still got the hard hat and high viz, happens every time I go on a site tour.

Can I keep them or do you want them back ?

Chester.

Hi KonarA

Am I being a bit thick but I don't understand what you are bumping.

Please explain...

Chester.

Hi KanorA

Thanks 2cvguy

Having thought I had seen 7-10 day's I just wanted to be sure. Hopefully Covidity will be treated as special case and processed with extreme haste.

Scancell could have chosen another country with a faster turnaround time if be South Africa had just said join the queue.

ATB

Chester.

Did I read correctly that the application to SAHPRA will be processed in a timescale of 7 to 10 days ?

If I did and it is actual days then we could expect an answer by next Friday the 2nd July. If it's working days which would surprise me, the latest would be the 6th.

Once we have the approval to start enrollment does anyone know roughly how long the trial will take to produce meaningful safety data ?

Chester.

Seems to me like promotional material setting up for SD's presentation next Thursday.

I would not be overly surprised if the twitter post and the coming presentation are not the preamble to bigger news, either exploration update or strategy on some of our other licenses.

Chester.

It is strange to stay on board as an investor, buy more shares when Vulpes arrived and now that the science is about to be finally tested in the clinic he announces he ready to sell out.

If the science proves to work anywhere near to its potential the demand for the shares will be huge.

So it is strange to pre-announce your intentions at such a pivotal moment in Scancell's journey.

Chester.

Paddy,

Ok think it's a back handed compliment. You have helped to inform private investors like myself and help to bolster our resolve to stay in the game. Which it now undoubtedly is.

The gear change in the SP is coming soon, either an MRE update on my the 28th July or we wait for PFS in September.

You are an asset to us all.

Chester.

Scancell News Pipeline :

1 ) SCIB1 / Keytruda Combi Trial. Update, Approved Trial Centres and Start Dates.

2 ) MODI1 - Conjugated Drug Manufacture Complete. Application to conduct a Trial. Confirmation of Trial Sites.

3 ) SCIB2 - What are we going to do now its definitely back in-house and now that we have a potential new delivery system or two.....?

4 ) AvidiMab and Glycan Mabs - What improvements have we been making and have we drafted up a few contacts ready to have signed off ?

5 ) Mab FG2811 - Are we going to develop this ourselves and will it spawn yet another platform.

6 ) Covidity Delivery System - Is Up and Running ? Will the Covidity safety trial prove its a Good Fit for future trials of Immunobody and Moditope.

7 ) Covidity - Cobra deal, the two possible drug formulations are SN15 and SN17.

8 ) Covidity - We await the SA trial approval RNS in the coming weeks.

9 ) Karolinska Institute collaboration seems to be focussed on Auto-Immune conditions.

10 ) BionTech collaboration will be more meaningful once we have MODI1 in the clinic.

11 ) With the new positions filled at Scancell are we planning our own Car-T platform ?

So much potential in one small Bio-tech, would it be a better senario to division off the different platforms, answer probably, yes.....

Chester

Your welcome ProfQ

There have been unfounded comments about SD after all he has only just taken the reigns. Must be a huge amount to get your head around and then your the man in the hot seat and have to start calling the shots, so I'm looking forward to seeing how comfortable he now is after a few months.

Next Thursday is an important moment in his development as our leader after Gervaise gained nearly cult status.

Chester.

Proactive Investors ONEtoONE link

https://www.google.com/url?sa=t&source=web&rct=j&url=https://www.proactiveinvestors.co.uk/register/event_details/347&ved=2ahUKEwjo8P6jo67xAhUSExQKHRqUAPAQFjACegQIGRAC&usg=AOvVaw2vMN1P-TqpLSVpA7DZvrDf

Has everyone signed up for next week's ONEtoONE presentation?

I don't know what the limit is on how many can be online at one time but I would think there will be a good 50 to 100 GGP'ers waiting to hear from Shaun Day. The Q&A session will give us an opportunity to ask some probing questions about why the 2021 drilled mtrs reported, has been so low compared to the start of year promise of 60,000 mtrs by end June. There are some obvious reasons but it would be good to hear Shaun's take on that subject.

Also, the JV drilling especially now it looks like they have moved on from Goliath, what are the early indications ?

Really looking forward to it....

Chester.

Hi WTP

I don't think anyone outside Scancell will nail their colours to our mast until the 'in human' safety data gives the greenlight.

I don't think Matt Hanclock will put his name on it until it has passed that process.

Just my opinion but sounds right to me ......... Lol

Chester.

Thanks C7 same to your good self,

The SP change will happen especially when the Safety Trial reports back, until then Covidity is kind of unproven, other than the lab results obviously. I think because we have followed the Scancell story through thick and thin we don't appreciate how it is still a diamond in the rough and we are not that well known outside the cancer vaccine sphere.

If the trial results are anywhere near our expectations those results will do all the talking.

Chester.

Hiya C7

I've seized my chance this morning and added to my long term hold.

I'm convinced that we're in a new phase of Scancell's development.

It will be interesting to compare where we are now with the SP and the lack of mainstream interest with where we could be in just one short month.

Chester.

Hi Scousemark

At this precise moment we have only asked for permission to start a 'Safety Trial in South Africa'. The news flow will begin with Trail Approval, then Patient Enrolment ( I would suggest that we are already canvassing for volunteers ), then First Patient dosed in 'Covidity Safety Trial RNS' and finally the data somewhere around End July / Mid August if everything is processed quickly.

Also, we are expecting some news on the MODI1 Trial Submission this next week ( H1 ).

Plus now it's in the public domain, a full explanation of the shell company set up, maybe.

I'm like you, very surprised at the lack of interest in the stock, it will change, its all about sentiment.

Chester.

TF the Covid Subsidiary should be called ......

'Aponia Vax Bio-Science'.

..... : )

Chester.